Stock tips I am buying this week (and they all begin with A)! 2026-09-21

I have put in for some limit orders on three of the following US stocks today and I am also watching Moderna closely too but not yet buying at the current price...

For research I used the free stock list app HelloStocks.ai (S&P only) and SimplyWallStreet for the first three A stocks. I picked them for value, future growth and health. Moderna is my own (very risky) pick.

Moderna was NOT identified by HelloStocks...

The first three (all beginning with A coincidentally) are thus my sensible picks for growth within one year. They all seem to have been undervalued for quite a while. These three thus have good value, have good health and good future prospects.

I already hold about £4k of AMAT but I will be topping up this week if when my limit order goes through.

Moderna is my own risky and volatile pick - it had a large jump of 145% in August but I am looking for a dip before I buy in.

Here is the chart of these four stocks using my new free trend tool...

I identified these from HelloStocks as good value - here is the complete chart of HelloStocks S&P 500 picks plotted in my trend chart tool after quickly adding them to a new portfolio group...

Period is 1 year

My Moderna pick

Moderna stock surged more than 8% on Friday, extending one of the wildest stretches in large-cap biotech after investors continued to reprice the company around its experimental personalized cancer vaccine. Shares were trading around $148.13 at 11:45 a.m. ET, up $11.51 from the previous close, according to Seeking Alpha, but the latest move came without a new major clinical announcement. Instead, the stock is still digesting the shockwave from Moderna and Merck’s landmark August Phase 3 melanoma results, which transformed the investment case almost overnight and sent traders scrambling to decide how much of a future oncology franchise should already be reflected in Moderna’s valuation.

That distinction matters because Friday’s 8% gain is not the beginning of the story. It is a continuation of a much larger repricing that started on August 19, when Moderna and Merck said their individualized mRNA therapy intismeran autogene, used alongside Merck’s Keytruda, met the primary endpoint of recurrence-free survival and a key secondary endpoint measuring distant metastasis-free survival in a large Phase 3 melanoma study. The announcement marked the first positive Phase 3 trial for an individualized neoantigen therapy and the first late-stage success for an mRNA-based cancer treatment, an achievement that pushed Moderna shares sharply higher and added tens of billions of dollars to the company’s market value.

Other drug companies

CEO & Executive Director of AstraZeneca recently bought UK£7.3m worth of stock

On the 14th of September, Pascal Claude Soriot bought around 60k shares on-market at roughly UK£121 per share. This transaction amounted to 17% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Pascal Claude's only on-market trade for the last 12 months.

I am watching closely AstraZeneca AZN which has had a large director buy recently and future price growth is expected. Note this also begins with A !!!

I already hold shares in Eli Lily LLY.

Best stock to buy this week?

According to SimplyWallStreet, Broadcom AVGO has a super-strong, almost perfect rating and is good value too...

I already hold £3.5k of this stock and may top up more this week.

Purely incidentally, AVGO also begins with A!

Other stocks that also begin with A and look good are ARM and AMD.

P.S. MRVL seem marvelous just now and I may buy more. I have set a stop loss just in case it dips though though...

WARNING: Please do your own research - these stocks are just ones I am buying or watching - they may not be suitable for you. Drug company stocks are extremely risky.

To calculate your shares capital gains for UK investors try my site www.ukcgt.xyz.

Subscribe for more posts and ideas! My T212 IRR is over 80% (GIA) and 45% (ISA) over a period of 30 months (£150k DCA'd over 30 months - currently at £200k value). That may be mostly due to luck in a bull market! I have over 20 years of investing experience and  have made £millions in gains in investments so far (I have investments in other broker accounts too). My philosophy is to mainly invest in steady global ETFs but I like to 'play' for higher gains with my £200k T212 portfolios. My risk level in my T212 account may not be your risk level! With all stocks, my main objective is not to lose money - the probability of making a gain should be at least 80% and the probability of the share price losing more than 20% over a year should be close to zero.